CSBR
Champions Oncology Inc
4.90$
-2.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -256.0% | – | – | -191.0% | – | +1,301.6% | -91.3% | -389.2% | – | – | – | – | |
| – | -0.6% | -5.0% | -1.8% | -11.1% | -0.3% | -1.0% | -9.1% | -0.3% | -4.5% | -5.9% | -2.2% | – | |
| – | +615.1% | -30.6% | -1.9% | -96.5% | +2,744.4% | -48.8% | +58.8% | +19.7% | +69.9% | -15.6% | +114.6% | – | |
| – | -78.6% | -960.5% | – | – | – | – | -97.4% | -1,610.1% | – | -186.0% | – | – | |
| – | -17.6% | -11.9% | -100.0% | – | -55.3% | +502.4% | -81.8% | +426.1% | -84.7% | +545.9% | -77.0% | – | |
| – | -39.9% | – | – | – | -55.3% | +502.4% | -81.8% | +426.1% | -94.2% | +1,600.0% | -76.9% | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +0.0% | +2.7% | +0.0% | +0.0% | +2.6% | +0.0% | -51.3% | +0.0% | – | |
| – | -116.3% | +326.5% | -74.5% | – | -100.0% | – | -56.3% | – | -121.4% | -47.2% | – | – | |
| – | -262.3% | – | – | -150.4% | – | +1,369.4% | -91.8% | -435.0% | – | – | – | – | |
| – | -339.7% | – | – | -221.2% | – | +1,376.6% | -91.6% | -456.9% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.